Velizar S. Shivarov

Sofia, 1618, Bulgaria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 64 publications

Characterisation of a Novel HLA-DQA1 Allele by Next Generation Sequencing: HLA-DQA1*01:03:13.

Characterisation of a Novel HLA-DQA1 Allele by Next Generation Sequencing: HLA-DQA1*01:03:13.

Journal: HLA
Published: August 01, 2026

Drug Safety and Polypharmacy Signals in Ibrutinib-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Age- and Sex-Specific FAERS Analysis of CYP3A Modifier and Antithrombotic Co-Exposure.

Drug Safety and Polypharmacy Signals in Ibrutinib-Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Age- and Sex-Specific FAERS Analysis of CYP3A Modifier and Antithrombotic Co-Exposure.

Journal: Journal of clinical medicine
Published: July 07, 2026

Checkpoint Blockade and Acquired Humoral Immune Dysregulation: Emerging Evidence for Antibody Deficiency During Long-Term PD-1/PD-L1 Inhibition.

Checkpoint Blockade and Acquired Humoral Immune Dysregulation: Emerging Evidence for Antibody Deficiency During Long-Term PD-1/PD-L1 Inhibition.

Journal: Cancers
Published: June 27, 2026

Breast Implant Illness and Autoimmune/Inflammatory Syndrome Induced by Adjuvants: Mechanistic Rationale and a Practical Multidisciplinary Diagnostic Algorithm.

Breast Implant Illness and Autoimmune/Inflammatory Syndrome Induced by Adjuvants: Mechanistic Rationale and a Practical Multidisciplinary Diagnostic Algorithm.

Journal: Journal of clinical medicine
Published: June 27, 2026

Unsupervised 20-feature immunohistochemical immune profiling identifies exploratory cervical cancer phenotypes with unfavorable survival signals.

Unsupervised 20-feature immunohistochemical immune profiling identifies exploratory cervical cancer phenotypes with unfavorable survival signals.

Journal: Frontiers in oncology
Published: June 20, 2026

Inhibitory HLA-C/KIR2DL2 Interactions and KIR Allelic Polymorphisms Are Associated With Susceptibility to Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Inhibitory HLA-C/KIR2DL2 Interactions and KIR Allelic Polymorphisms Are Associated With Susceptibility to Philadelphia Chromosome-Negative Myeloproliferative Neoplasms.

Journal: EJHaem
Published: June 06, 2026

Immune-related adverse events in Hodgkin lymphoma treated with pembrolizumab or nivolumab: A disease-restricted US Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance analysis.

Immune-related adverse events in Hodgkin lymphoma treated with pembrolizumab or nivolumab: A disease-restricted US Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance analysis.

Journal: British journal of haematology
Published: May 16, 2026

Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms.

Immunogenetic and Transcriptomic Evidence Implicating the NKG2D-MICA/MICB Axis in CALR-Mutated Myeloproliferative Neoplasms.

Journal: Cancers
Published: April 26, 2026

ROMO1 as a Diagnostic Biomarker in Cervical Neoplasia: Evidence from Normal, Pre-Invasive, and Invasive Lesions.

ROMO1 as a Diagnostic Biomarker in Cervical Neoplasia: Evidence from Normal, Pre-Invasive, and Invasive Lesions.

Journal: Diagnostics (Basel, Switzerland)
Published: November 14, 2025

Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination.

Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination.

Journal: Vaccines
Published: June 11, 2025

Characterisation of the Novel KIR2DL3*038 Allele by Next Generation Sequencing.

Characterisation of the Novel KIR2DL3*038 Allele by Next Generation Sequencing.

Journal: HLA
Published: June 09, 2025

Clinical Significance of Tumor Infiltrating T-Helper and Regulatory Cells in Bulgarian Cervical Cancer Patients.

Clinical Significance of Tumor Infiltrating T-Helper and Regulatory Cells in Bulgarian Cervical Cancer Patients.

Journal: Biomedicines
Published: June 07, 2025
Showing 1-12 of 64

Last Updated: 09/26/2026